VP Pharma
DIAMANTE Healthcare
St. Gingolph, Switzerland
Preclinical, clinical, regulatory and technical advisor for biotech start ups and MedTech including full project management and operational support within the clients company.
I develop new life-saving medicines for biotech start-ups, with strategic project management and matching investors' requirements. Human. Empathetic. Unconventional.
I'm a drug development executive with over 25 years of experience in drug discovery, pre-clinical and clinical drug development, medical devices, and life-cycle management across cardiovascular, respiratory, oncology, metabolic, CNS and rare genetic diseases.
After his specialization in clinical pharmacokinetics at Boehringer Ingelheim, he has successfully led multiple global cross-functional development programs from preclinical discovery through Phase 3 and regulatory approval at ALTANA Pharma (now Takeda), Actelion (now J&J) and Idorsia, including multiple IND filings and the submission and approval of three NDAs/MAAs in US, EU, Japan, and South Korea.
His expertise spans preclinical development, clinical development & biomarker strategy, orphan disease development, regulatory interactions, CMC, and commercialization strategies. He has significant experience in managing alliances, licensing opportunities, and cross-industry collaborations.
Expertise
Profit from clinical and regulatory development, scientific and technical consulting expertise, as well as hands-on operational support in day-to-day project execution - and concomitant outreach to our investors and strategic network